Xinyi Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xinyi Yang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- A. S. Howard
University of Ljubljana
1 shared publication - Bohu Liu
Shenyang Institute of Automation, Chinese Academy of Sciences 2 , Shengyang, Liaoning 110169, China
1 shared publication - C. Yu
Institute of High Energy Physics
1 shared publication - Dejun Han
Beijing Normal University
1 shared publication Gangxian Chen
Bone and Soft Tissue Tumors Research Centre of Yunnan Province, Department of Orthopaedics, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, China
1 shared publication- Gregor Kramberger
University of Ljubljana
1 shared publication
Latest Publications
- Open Access
- 28 January 2023
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-10
The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer
M6A is an important RNA methylation in progression of various human cancers. As the m6A reader protein, YTHDF1 is reported to accelerate m6A-modified mRNAs translation in cytoplasm. It is highly expressed in various human cancers and contributes to the progression and metastasis of cancers. YTHDF1 was closely associated with poor prognosis and also used as a molecular marker for clinical diagnosis or therapy in human cancers. It has been reported to promote chemoresistance to Adriamycin, Cisplatin and Olaparib by increasing mRNA stability of its target molecule. Moreover, it contributes to CSC-like characteristic of tumor cells and inducing the antitumor immune microenvironment. Here, we reviewed the clinical diagnostic and prognostic values of YTHDF1, as well as the molecular mechanisms of YTHDF1 in progression and metastasis of human cancers.
- 28 January 2023
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-10
Open AccessThe potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer
M6A is an important RNA methylation in progression of various human cancers. As the m6A reader protein, YTHDF1 is reported to accelerate m6A-modified mRNAs translation in cytoplasm. It is highly expressed in various human cancers and contributes to the progression and metastasis of cancers. YTHDF1 was closely associated with poor prognosis and also used as a molecular marker for clinical diagnosis or therapy in human cancers. It has been reported to promote chemoresistance to Adriamycin, Cisplatin and Olaparib by increasing mRNA stability of its target molecule. Moreover, it contributes to CSC-like characteristic of tumor cells and inducing the antitumor immune microenvironment. Here, we reviewed the clinical diagnostic and prognostic values of YTHDF1, as well as the molecular mechanisms of YTHDF1 in progression and metastasis of human cancers.
- Open Access
- 1 August 2021
- Published by IOP Publishing in Journal of Instrumentation
- Vol. 16 (08) , P08053
The performance of IHEP-NDL LGAD sensors after neutron irradiation
- 1 August 2021
- Published by IOP Publishing in Journal of Instrumentation
- Vol. 16 (08) , P08053
Open AccessThe performance of IHEP-NDL LGAD sensors after neutron irradiation